These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 24354929

  • 1. The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia.
    Krysiak R, Zmuda W, Okopien B.
    Cardiovasc Ther; 2014 Apr; 32(2):40-6. PubMed ID: 24354929
    [Abstract] [Full Text] [Related]

  • 2. Age may determine the effect of hypolipidemic agents on plasma adipokine levels in patients with elevated low-density lipoprotein cholesterol levels.
    Krysiak R, Żmuda W, Marek B, Okopień B.
    Endokrynol Pol; 2016 Apr; 67(3):271-6. PubMed ID: 26884289
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of short-term hypolipidaemic treatment on plasma adipokine levels in men and women with isolated hypercholesterolaemia.
    Krysiak R, Żmuda W, Marek B, Okopień B.
    Endokrynol Pol; 2015 Apr; 66(2):114-20. PubMed ID: 25931040
    [Abstract] [Full Text] [Related]

  • 4. The effect of ezetimibe on adipose tissue hormones in patients with isolated hypercholesterolemia.
    Krysiak R, Żmuda W, Okopień B.
    Pharmacol Rep; 2014 Jun; 66(3):442-7. PubMed ID: 24905521
    [Abstract] [Full Text] [Related]

  • 5. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL, Batista MC, Ferreira SR.
    Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
    [Abstract] [Full Text] [Related]

  • 6. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS, Kim SH, Kim JK, Ko SH, Ko JE, Park SJ, Park MG, Lee JH, Hyon MS.
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of short-term combined treatment with simvastatin and ezetimibe on circulating adipokine levels in patients with isolated hypercholesterolemia.
    Krysiak R, Zmuda W, Marek B, Okopień B.
    Endokrynol Pol; 2014 Jul; 65(4):275-80. PubMed ID: 25185849
    [Abstract] [Full Text] [Related]

  • 9. The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia.
    Krysiak R, Okopien B.
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):505-12. PubMed ID: 21297492
    [Abstract] [Full Text] [Related]

  • 10. The effect of ezetimibe, administered alone or in combination with simvastatin, on lymphocyte cytokine release in patients with elevated cholesterol levels.
    Krysiak R, Zmuda W, Okopien B.
    J Intern Med; 2012 Jan; 271(1):32-42. PubMed ID: 21623963
    [Abstract] [Full Text] [Related]

  • 11. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 12. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 13. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 14. The effect of ezetimibe on androgen production in hypercholesterolemic women with polycystic ovary syndrome.
    Krysiak R, Zmuda W, Okopien B.
    Cardiovasc Ther; 2014 Oct; 32(5):219-23. PubMed ID: 25056604
    [Abstract] [Full Text] [Related]

  • 15. Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levels.
    Liberopoulos EN, Makariou SE, Moutzouri E, Kostapanos MS, Challa A, Elisaf M.
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):229-33. PubMed ID: 23288870
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 17. The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia.
    Krysiak R, Zmuda W, Okopień B.
    Fundam Clin Pharmacol; 2012 Jun; 26(3):424-31. PubMed ID: 21392096
    [Abstract] [Full Text] [Related]

  • 18. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM.
    J Clin Lipidol; 2011 Jun; 5(6):474-82. PubMed ID: 22108151
    [Abstract] [Full Text] [Related]

  • 19. Identical LDL-cholesterol lowering but non-identical effects on NF-κB activity: High dose simvastatin vs combination therapy with ezetimibe.
    Rudofsky G, Reismann P, Groener JB, Djuric Z, Fleming T, Metzner C, Grafe IA, Bierhaus A, Nawroth PP.
    Atherosclerosis; 2012 Jul; 223(1):190-6. PubMed ID: 22633472
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
    Foody JM, Brown WV, Zieve F, Adewale AJ, Flaim D, Lowe RS, Jones-Burton C, Tershakovec AM.
    Am J Cardiol; 2010 Nov 01; 106(9):1255-63. PubMed ID: 21029821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.